Hemolytic disease of the fetus and newborn (HDFN) imposes a significant burden on affected infants, with potential consequences extending beyond the newborn stage and into adolescence, according to results from a study published recently in BMC Pregnancy and Childbirth.
The study suggested children with HDFN could face a higher risk of developmental delays, cognitive challenges and emotional difficulties compared to their peers. Despite these findings, current evidence remains limited, highlighting the need for more comprehensive studies to understand the effect on patients and their families fully.
A recent systematic review analyzed 26 studies focusing on the patient experience and economic burden of HDFN across Europe, the Middle East, and Africa. The results indicated that while HDFN primarily affected newborns, its consequences may persist into childhood and adolescence. Children with a history of in utero transfusions for fetal anemia exhibited lower scores in cognitive and social functioning and emotional well-being, compared to population norms. In addition, some studies suggested a higher incidence of behavioral differences, such as increased anxiety and excitability, linked to disease severity.
“While the limited evidence indicates that HDFN does confer a burden on patients, the review identifies the need for further well-powered and representative observational studies using well-defined outcome measures to address the evidence gaps highlighted,” the authors of this study explained.
Read more about the prognosis of HDFN
Neurodevelopmental outcomes varied across studies, with some showing satisfactory progress in affected children, while others reported neurological impairments in up to 11.2% of cases. Academic development was also an area of concern, with one study noting a higher rate of grade repetition among children with HDFN. However, results were not entirely negative—some children with HDFN demonstrated above-average performance in certain subjects, suggesting a complex relationship between the condition and cognitive abilities.
Despite these insights, research on HDFN remains fragmented. Only one study directly measured patient-reported quality of life, and most studies relied on proxy measures such as academic performance and behavior assessments. In addition, methodological inconsistencies across studies make it difficult to draw firm conclusions about long-term outcomes. More well-designed observational research is needed to establish clearer patterns and identify factors that may contribute to better patient outcomes.
The economic burden of HDFN is also not well understood, as most studies focused on healthcare resource use rather than direct costs. The absence of detailed cost analyses leaves uncertainty about the financial strain on families and healthcare systems. Given the potential lifelong implications of HDFN, further research is needed to determine its full economic impact and explore ways to mitigate costs for affected families.
This review underscored the pressing need for broader, more standardized research efforts to better capture the true burden of HDFN. By improving understanding of the condition’s long-term effects, healthcare providers may be better equipped to support patients and develop interventions that enhance their quality of life.
Sign up here to get the latest news, perspectives, and information about HDFN sent directly to your inbox. Registration is free and only takes a minute.
